JP2006514665A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006514665A5 JP2006514665A5 JP2004568567A JP2004568567A JP2006514665A5 JP 2006514665 A5 JP2006514665 A5 JP 2006514665A5 JP 2004568567 A JP2004568567 A JP 2004568567A JP 2004568567 A JP2004568567 A JP 2004568567A JP 2006514665 A5 JP2006514665 A5 JP 2006514665A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- composition
- composition according
- administration
- tetraiodosilopionic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 46
- 239000002253 acid Substances 0.000 claims 30
- 238000002360 preparation method Methods 0.000 claims 8
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 claims 6
- 238000009472 formulation Methods 0.000 claims 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 4
- 230000000202 analgesic effect Effects 0.000 claims 2
- 239000000730 antalgic agent Substances 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 claims 2
- 230000003078 antioxidant effect Effects 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000001802 infusion Methods 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 238000001990 intravenous administration Methods 0.000 claims 2
- 239000007951 isotonicity adjuster Substances 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 235000019260 propionic acid Nutrition 0.000 claims 2
- 210000001147 pulmonary artery Anatomy 0.000 claims 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 239000003381 stabilizer Substances 0.000 claims 2
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 230000036765 blood level Effects 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/368,755 US6716877B2 (en) | 2001-01-31 | 2003-02-18 | Method to treat chronic heart failure and/or elevated cholesterol levels |
| PCT/US2003/033333 WO2004073694A1 (en) | 2003-02-18 | 2003-10-20 | Method to treat chronic heart failure and/or elevated cholesterol levels |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006514665A JP2006514665A (ja) | 2006-05-11 |
| JP2006514665A5 true JP2006514665A5 (https=) | 2006-06-29 |
Family
ID=32907645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004568567A Pending JP2006514665A (ja) | 2003-02-18 | 2003-10-20 | 慢性心不全および／または上昇したコレステロールレベルを処置するための方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6716877B2 (https=) |
| EP (1) | EP1594480A4 (https=) |
| JP (1) | JP2006514665A (https=) |
| AU (1) | AU2003286546B2 (https=) |
| CA (1) | CA2516450A1 (https=) |
| MX (1) | MXPA05008596A (https=) |
| WO (1) | WO2004073694A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI107018B (fi) * | 2000-04-06 | 2001-05-31 | Ipsat Therapies Oy | Dermatologinen käyttö ja valmiste |
| US7504435B2 (en) * | 2001-01-31 | 2009-03-17 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method for stimulating weight loss and/or for lowering triglycerides in patients |
| WO2006128058A2 (en) | 2005-05-26 | 2006-11-30 | Metabasis Therapeutics, Inc. | Thyromimetics for the treatment of fatty liver diseases |
| CN1882327A (zh) * | 2003-11-19 | 2006-12-20 | 症变治疗公司 | 含磷的新的拟甲状腺素药 |
| WO2006128056A2 (en) * | 2005-05-26 | 2006-11-30 | Metabasis Therapeutics, Inc. | Novel phosphinic acid-containing thyromimetics |
| EP2199271A4 (en) * | 2007-08-31 | 2011-05-18 | Mitsubishi Gas Chemical Co | METHOD FOR PRODUCING PHENOL DERIVATIVES SUBSTITUTED WITH IODINE AT THE ORTHO POSITION |
| US20090131380A1 (en) * | 2007-11-16 | 2009-05-21 | Pekka Heino | Novel pharmaceutical composition for topical treatment of skin psoriasis and the treatment method thereof |
| MX386702B (es) * | 2014-02-10 | 2025-03-19 | Fred Hutchinson Cancer Center | Tratamiento con halogeno de ataque cardiaco y lesion isquemica. |
| CA3044059A1 (en) | 2016-11-21 | 2018-05-24 | Viking Therapeutics, Inc. | Method of treating glycogen storage disease |
| US11707472B2 (en) | 2017-06-05 | 2023-07-25 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis |
| US11458094B2 (en) * | 2018-01-31 | 2022-10-04 | Regents Of The University Of Minnesota | Compositions and methods for treating pulmonary edema or lung inflammation |
| ES3053674T3 (en) | 2018-03-22 | 2026-01-23 | Viking Therapeutics Inc | Crystalline forms and methods of producing crystalline forms of a compound |
| WO2020117962A1 (en) | 2018-12-05 | 2020-06-11 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis and inflammation |
| CA3177377A1 (en) | 2020-03-27 | 2021-09-30 | Regents Of The University Of Minnesota | Compositions and methods for treating pulmonary edema or lung inflammation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3109023A (en) | 1958-06-10 | 1963-10-29 | Hooker Chemical Corp | 2, 3, 6-trichloro-5-nitrobenzoic acid and salts thereof |
| US5158978A (en) * | 1990-02-05 | 1992-10-27 | British Technology Group (U.S.A.) | Thyroid hormone treatment of acute cardiovascular compromise |
| US5284971A (en) | 1992-07-16 | 1994-02-08 | Syntex (U.S.A.) Inc. | 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents |
| US6221911B1 (en) * | 1995-06-07 | 2001-04-24 | Karo Bio Ab | Uses for thyroid hormone compounds or thyroid hormone-like compounds |
| US5883294A (en) | 1997-06-18 | 1999-03-16 | The Regeants Of The University Of California | Selective thyroid hormone analogs |
| US6534676B2 (en) * | 2001-01-31 | 2003-03-18 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same |
-
2003
- 2003-02-18 US US10/368,755 patent/US6716877B2/en not_active Expired - Fee Related
- 2003-10-20 AU AU2003286546A patent/AU2003286546B2/en not_active Ceased
- 2003-10-20 JP JP2004568567A patent/JP2006514665A/ja active Pending
- 2003-10-20 CA CA002516450A patent/CA2516450A1/en not_active Abandoned
- 2003-10-20 WO PCT/US2003/033333 patent/WO2004073694A1/en not_active Ceased
- 2003-10-20 MX MXPA05008596A patent/MXPA05008596A/es active IP Right Grant
- 2003-10-20 EP EP03777748A patent/EP1594480A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006514665A5 (https=) | ||
| JP5185488B2 (ja) | ２−（４−イソブチルフェニル）プロピオン酸の医薬組成物 | |
| CA2436421A1 (en) | Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same | |
| JP2017132791A (ja) | 組み合わせ組成物 | |
| AU2012290987B2 (en) | Left ventricular diastolic function improving agent | |
| WO2003103659A1 (ja) | 過活動膀胱治療剤 | |
| JP5680412B2 (ja) | レオヌリンの使用およびその組成物 | |
| US9107930B2 (en) | Method for treating unwanted localized fat deposits | |
| JP2012532852A (ja) | ２型糖尿病における食後高血糖の経頬粘膜治療の方法、および当該治療に用いられる医薬組成物 | |
| Baumgartner | Rocuronium and sugammadex in myotonic dystrophy. | |
| KR101010411B1 (ko) | 온단세트론의 직장내 투여를 위한 온도 감응성 액상좌제조성물 | |
| EP2846776B1 (en) | Parenteral esmolol formulation | |
| JP2022089867A (ja) | 安定なイブプロフェン注射製剤用組成物 | |
| JP2008189626A (ja) | 経口用グリチルリチン可溶化製剤及びその製造方法 | |
| WO2016102463A1 (en) | Combination of remifentanil and propofol | |
| Sellgren et al. | Anesthetic modulation of the cardiovascular response to microlaryngoscopy | |
| CN115990166B (zh) | 一种预防ct造影剂肾病的药物组合物及其用途 | |
| WO2023014748A1 (en) | Nitrated fatty acids for the treatment of sickle cell disorders | |
| RU2329799C1 (ru) | Способ анестезии при проведении адреналэктомии по поводу феохромоцитомы надпочечника | |
| CN1878549A (zh) | 透皮吸收型脑保护剂 | |
| Lee et al. | Clinical profile of a new anesthetic: remimazolam | |
| WO2004069236A9 (ja) | 周術期血糖値上昇抑制剤 | |
| JP2004231557A (ja) | エピネフリン含有抗腫瘍剤 | |
| TWI353257B (https=) | ||
| JP2002538119A (ja) | 血圧低下のためのレミフェンタニルの使用 |